Published in Clin Infect Dis on September 01, 1996
Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob Agents Chemother (1997) 1.95
Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan. Eur J Clin Microbiol Infect Dis (1997) 1.75
Genetic diversity of carbapenem-hydrolyzing metallo-beta-lactamases from Chryseobacterium (Flavobacterium) indologenes. Antimicrob Agents Chemother (2000) 1.68
Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods. Antimicrob Agents Chemother (1997) 1.34
Chryseobacterium indologenes infection in a newborn: a case report. J Med Case Rep (2011) 1.20
Comparison of Etest and agar dilution method for antimicrobial susceptibility testing of Flavobacterium isolates. J Clin Microbiol (1997) 0.92
Chryseobacterium indologenes peritonitis in peritoneal dialysis. BMJ Case Rep (2013) 0.91
Flavobacterium ceti From Blood Samples of a Korean Patient With Alcoholic Liver Cirrhosis. Ann Lab Med (2015) 0.89
Chryseobacterium indologenes peritonitis in a patient with malignant ascites. Int Med Case Rep J (2011) 0.85
Unforeseeable presentation of Chryseobacterium indologenes infection in a paediatric patient. BMC Res Notes (2016) 0.83
Susceptibilities of Chryseobacterium indologenes and Chryseobacterium meningosepticum to cefepime and cefpirome. J Clin Microbiol (1997) 0.83
Chryseobacterium indologenes Septicemia in an Infant. Case Rep Infect Dis (2014) 0.82
Chryseobacterium indologenes in a woman with metastatic breast cancer in the United States of America: a case report. J Med Case Rep (2013) 0.81
Emerging flavobacterial infections in fish: A review. J Adv Res (2014) 0.80
Whole genome sequencing uncovers a novel IND-16 metallo-β-lactamase from an extensively drug-resistant Chryseobacterium indologenes strain J31. Gut Pathog (2016) 0.75
Ventilator-associated pneumonia caused by Chryseobacterium indologenes: a rare infant case and review of the literature. Springerplus (2016) 0.75
Chryseobacterium indologenes, a possible emergent organism resistant to carbapenem antimicrobials after stem cell transplantation. Clin Case Rep (2016) 0.75
Draft genome sequence of a multidrug-resistant Chryseobacterium indologenes isolate from Malaysia. Genom Data (2015) 0.75
Recurrent port infection due to chryseobacterium indologenes. Eurasian J Med (2013) 0.75
Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother (2001) 4.72
Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan. Antimicrob Agents Chemother (2000) 2.96
Comparison of aminoglycoside resistance patterns in Japan, Formosa, and Korea, Chile, and the United States. Antimicrob Agents Chemother (1985) 2.66
Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature (1995) 2.48
Severe community-acquired pneumonia due to Acinetobacter baumannii. Chest (2001) 2.46
Comparison of the BACTEC MGIT 960 with Löwenstein-Jensen medium for recovery of mycobacteria from clinical specimens. Int J Tuberc Lung Dis (2000) 2.29
Identification of a plasmid encoding SHV-12, TEM-1, and a variant of IMP-2 metallo-beta-lactamase, IMP-8, from a clinical isolate of Klebsiella pneumoniae. Antimicrob Agents Chemother (2001) 2.21
Clinical and microbiological characteristics of Flavobacterium indologenes infections associated with indwelling devices. J Clin Microbiol (1996) 2.19
Predicting factors for outcome of tube thoracostomy in complicated parapneumonic effusion for empyema. Chest (1999) 2.19
Dissemination of CTX-M-3 and CMY-2 beta-lactamases among clinical isolates of Escherichia coli in southern Taiwan. J Clin Microbiol (2000) 2.11
Rapidly fatal outcome of bacteremic Klebsiella pneumoniae pneumonia in alcoholics. Chest (1995) 2.02
Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. Cancer Cells (1991) 1.95
Outbreak of infection with multidrug-resistant Klebsiella pneumoniae carrying bla(IMP-8) in a university medical center in Taiwan. J Clin Microbiol (2001) 1.88
Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection. Infect Immun (1998) 1.84
Small repeating units within the Ureaplasma urealyticum MB antigen gene encode serovar specificity and are associated with antigen size variation. Infect Immun (1995) 1.84
Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis. J Antimicrob Chemother (1998) 1.80
Fungal empyema thoracis: an emerging clinical entity. Chest (2000) 1.80
Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes. J Clin Microbiol (1999) 1.77
Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan. Eur J Clin Microbiol Infect Dis (1997) 1.75
PapG II adhesin in the establishment and persistence of Escherichia coli infection in mouse kidneys. Kidney Int (2007) 1.73
Severe immune hemolytic anemia in disseminated tuberculosis with response to antituberculosis therapy. Chest (2001) 1.73
Collagen type IX: evidence for covalent linkages to type II collagen in cartilage. FEBS Lett (1987) 1.69
Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan. Clin Microbiol Infect (2005) 1.67
Klebsiella pneumoniae isolates causing liver abscess in Taiwan. Diagn Microbiol Infect Dis (2000) 1.65
Control of the initiation of sporulation in Bacillus subtilis by a phosphorelay. Res Microbiol (1992) 1.64
Cryptococcal meningitis in non-HIV-infected patients. QJM (2000) 1.63
Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob Agents Chemother (1995) 1.61
Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia. J Infect (2000) 1.61
Tuberculous myositis: a rare but existing clinical entity. Rheumatology (Oxford) (2003) 1.61
Staphylococcus aureus meningitis in adults: a clinical comparison of infections caused by methicillin-resistant and methicillin-sensitive strains. Infection (2001) 1.60
Bacteremia caused by Arcobacter cryaerophilus 1B. J Clin Microbiol (1997) 1.59
Serodiagnosis of tuberculosis. A study comparing three specific mycobacterial antigens. Am J Respir Crit Care Med (1997) 1.55
Melioidosis: an emerging infection in Taiwan? Emerg Infect Dis (2001) 1.55
Effect of group A streptococcal cysteine protease on invasion of epithelial cells. Infect Immun (1998) 1.54
Etanercept as prophylactic psoriatic therapy before interferon-alpha and ribavirin treatment for active hepatitis C infection. Clin Exp Dermatol (2009) 1.53
Changes in cartilage composition and physical properties due to stromelysin degradation. Arthritis Rheum (1995) 1.52
Persistence of a multidrug-resistant Pseudomonas aeruginosa clone in an intensive care burn unit. J Clin Microbiol (1998) 1.52
Clinical and microbiological characteristics of bacteremia caused by Acinetobacter lwoffii. Eur J Clin Microbiol Infect Dis (2000) 1.51
Actinobacillus actinomycetemcomitans pneumonia with chest wall involvement and rib destruction. Chest (1992) 1.50
Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer. J Clin Oncol (2001) 1.50
Needle aspiration biopsy of malignant lung masses with necrotic centers. Improved sensitivity with ultrasonic guidance. Chest (1993) 1.48
Mutational dissociation of the positive and negative regulatory properties of the Spo0A sporulation transcription factor of Bacillus subtilis. Gene (1991) 1.44
Extremely high incidence of macrolide and trimethoprim-sulfamethoxazole resistance among clinical isolates of Streptococcus pneumoniae in Taiwan. J Clin Microbiol (1999) 1.44
A positive feedback loop controls transcription of the spoOF gene, a component of the sporulation phosphorelay in Bacillus subtilis. Mol Microbiol (1993) 1.42
Klebsiella pneumoniae meningitis: timing of antimicrobial therapy and prognosis. QJM (2000) 1.40
Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer. Am J Respir Crit Care Med (2000) 1.39
Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993. Infect Control Hosp Epidemiol (1997) 1.38
Outbreak of Pseudomonas fluorescens bacteremia among oncology patients. J Clin Microbiol (1998) 1.37
High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. Antimicrob Agents Chemother (2001) 1.36
Emergence of vancomycin-resistant enterococci at a university hospital in Taiwan: persistence of multiple species and multiple clones. Infect Control Hosp Epidemiol (1999) 1.34
Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods. Antimicrob Agents Chemother (1997) 1.34
Value of sonography in determining the nature of pleural effusion: analysis of 320 cases. AJR Am J Roentgenol (1992) 1.34
Erythrocyte sedimentation rate and C-reactive protein values in patients with total hip arthroplasty. Clin Orthop Relat Res (1987) 1.34
Catalytic growth and characterization of gallium nitride nanowires. J Am Chem Soc (2001) 1.33
Paraneoplastic pemphigus in association with a retroperitoneal Castleman's disease presenting with a lichen planus pemphigoides-like eruption. A case report and review of literature. Br J Dermatol (2001) 1.33
Evaluation of ultrasonically guided biopsies of mediastinal masses. Chest (1991) 1.28
Recurrent bacteremic peritonitis caused by Enterococcus cecorum in a patient with liver cirrhosis. J Clin Microbiol (2000) 1.27
Empyema thoracis and lung abscess caused by viridans streptococci. Am J Respir Crit Care Med (1997) 1.26
Arcobacter butzleri bacteremia in a patient with liver cirrhosis. J Formos Med Assoc (2000) 1.26
Glucosyltransferase gene polymorphism among Streptococcus mutans strains. Infect Immun (1991) 1.26
Collagen of fibrocartilage: a distinctive molecular phenotype in bovine meniscus. FEBS Lett (1983) 1.26
Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae strains isolated in southern Taiwan. J Formos Med Assoc (1996) 1.25
Molecular evidence for strain dissemination of Penicillium marneffei: an emerging pathogen in Taiwan. J Infect Dis (2000) 1.25
Pulmonary fungal infection: emphasis on microbiological spectra, patient outcome, and prognostic factors. Chest (2001) 1.25
Septic shock due to Helicobacter fennelliae in a non-human immunodeficiency virus-infected heterosexual patient. J Clin Microbiol (1999) 1.24